Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

DGX Quest Diagnostics Inc

Price (delayed)

$171.38

Market cap

$19.13B

P/E Ratio

21.4

Dividend/share

$3.05

EPS

$8.01

Enterprise value

$25.51B

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
Quest Diagnostics's quick ratio has increased by 41% YoY and by 29% QoQ
The revenue has grown by 9% YoY and by 2.9% from the previous quarter
Quest Diagnostics's debt has increased by 23% YoY but it has decreased by 5% QoQ
DGX's price to earnings (P/E) is 40% higher than its 5-year quarterly average of 15.3 and 8% higher than its last 4 quarters average of 19.9

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
111.64M
Market cap
$19.13B
Enterprise value
$25.51B
Valuations
Price to earnings (P/E)
21.4
Price to book (P/B)
2.74
Price to sales (P/S)
1.87
EV/EBIT
18.38
EV/EBITDA
13.39
EV/Sales
2.51
Earnings
Revenue
$10.16B
Gross profit
$3.34B
Operating income
$1.39B
Net income
$897M
EBIT
$1.39B
EBITDA
$1.91B
Free cash flow
$1.06B
Per share
EPS
$8.01
EPS diluted
$7.91
Free cash flow per share
$9.51
Book value per share
$62.44
Revenue per share
$91.51
TBVPS
$47.05
Balance sheet
Total assets
$15.8B
Total liabilities
$8.84B
Debt
$6.57B
Equity
$6.93B
Working capital
$634M
Liquidity
Debt to equity
0.95
Current ratio
1.44
Quick ratio
1.1
Net debt/EBITDA
3.35
Margins
EBITDA margin
18.8%
Gross margin
32.8%
Net margin
8.8%
Operating margin
13.7%
Efficiency
Return on assets
5.8%
Return on equity
13.2%
Return on invested capital
14.8%
Return on capital employed
9.7%
Return on sales
13.7%
Dividend
Dividend yield
1.78%
DPS
$3.05
Payout ratio
38.1%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-1.32%
1 week
0.53%
1 month
-3%
1 year
23.37%
YTD
13.6%
QTD
1.29%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$10.16B
Gross profit
$3.34B
Operating income
$1.39B
Net income
$897M
Gross margin
32.8%
Net margin
8.8%
DGX's operating income is up by 11% year-on-year and by 3.4% since the previous quarter
The revenue has grown by 9% YoY and by 2.9% from the previous quarter
The gross profit has increased by 9% YoY and by 2.8% from the previous quarter
The net income has grown by 6% YoY and by 3% from the previous quarter

Price vs fundamentals

How does DGX's price correlate with its fundamentals

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
P/E
21.4
P/B
2.74
P/S
1.87
EV/EBIT
18.38
EV/EBITDA
13.39
EV/Sales
2.51
DGX's price to earnings (P/E) is 40% higher than its 5-year quarterly average of 15.3 and 8% higher than its last 4 quarters average of 19.9
DGX's EPS is up by 6% year-on-year and by 3% since the previous quarter
The stock's price to book (P/B) is 10% more than its last 4 quarters average of 2.5 and 5% more than its 5-year quarterly average of 2.6
Quest Diagnostics's equity has increased by 8% YoY and by 2.2% from the previous quarter
The stock's price to sales (P/S) is 10% more than its 5-year quarterly average of 1.7 and 3.9% more than its last 4 quarters average of 1.8
The revenue has grown by 9% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is Quest Diagnostics business performance
Quest Diagnostics's return on invested capital has decreased by 10% YoY and by 4.5% QoQ
DGX's return on assets is down by 6% year-on-year

Dividends

What is DGX's dividend history
DPS
$3.05
Dividend yield
1.78%
Payout ratio
38.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 79% greater than the total liabilities
The current ratio has increased by 48% YoY and by 31% QoQ
Quest Diagnostics's quick ratio has increased by 41% YoY and by 29% QoQ
Quest Diagnostics's debt is 5% lower than its equity
Quest Diagnostics's debt has increased by 23% YoY but it has decreased by 5% QoQ
The company's debt to equity rose by 14% YoY but it fell by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.